Responsibilities
P11 - The soluble Interleukin-2 Receptor as a potential predictive biomarker for toxicity and efficacy of immune checkpoint inhibitor therapy with and without chemotherapy in non-small cell lung cancer
Contact
Department of Pneumology
University Hospital of Munich
Ziemssenstr. 1/5
80336 München
University Hospital of Munich
Ziemssenstr. 1/5
80336 München
Work group
Tufman Lab